Company / Gross Profit
Collegium Pharmaceutical, Inc. Gross Profit History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$463.3M
FY2025
5-year range
$150.6M / $463.3M
FY2021-FY2025
Trend
+22.8%
vs FY2024
Sector context
#15 of 29
Health Care
What the data says
At $463M, Collegium Pharmaceutical, Inc.'s gross profit ranks #15 of 29 in the Health Care sector. Gross Profit has increased for 4 consecutive years, from $151M in FY2021 to $463M in FY2025.
Based on SEC 10-K filings.
$463M in FY2025 with a 5-year CAGR of +20.8%.
Improved from $326M to $463M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +30.3%
- 5-Year CAGR
- +20.8%
- 10-Year CAGR
- -
Sector benchmark
#15 of 29 in Health CareTop 52% of 29This company $463.3M Sector average $3.5B
▼
-86.6% below sector average
Key checks
Key Insights
- Collegium Pharmaceutical, Inc.'s gross profit has grown for 4 consecutive years.
- 5-year CAGR of +20.8%, indicating consistent growth.
- In FY2025, gross profit increased 22.8% year-over-year.
- Ranks #15 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $463.3M | +22.8% |
| FY2024 | $377.3M | +15.7% |
| FY2023 | $326.2M | +55.7% |
| FY2022 | $209.5M | +39.1% |
| FY2021 | $150.6M | -16.2% |
| FY2020 | $179.8M | +74.5% |
| FY2019 | $103.0M | -10.2% |
| FY2018 | $114.7M | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026